HLA-G and MHC Class II Protein Expression in Diffuse Large B-Cell Lymphoma-Reference-Cited by-同舟云学术

HLA-G and MHC Class II Protein Expression in Diffuse Large B-Cell Lymphoma

Published:2015-12-14 Issue:3 Volume:64 Page:225-240
ISSN:0004-069X
Container-title:Archivum Immunologiae et Therapiae Experimentalis
language:en
Short-container-title:Arch. Immunol. Ther. Exp.

Author:

Jesionek-Kupnicka Dorota,Bojo Marcin,Prochorec-Sobieszek Monika,Szumera-Ciećkiewicz Anna,Jabłońska Joanna,Kalinka-Warzocha Ewa,Kordek Radzisław,Młynarski Wojciech,Robak Tadeusz,Warzocha Krzysztof,Lech-Maranda Ewa

Funder

National Science Centre, Poland

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00005-015-0372-8.pdf

Reference52 articles.

1. Amiot L, Onno M, Renard I et al (1996) HLA-G transcription studies during the different stages of normal and malignant hematopoiesis. Tissue Antigens 48:609–614

2. Amiot L, Onno M, Lamy T et al (1998) Loss of HLA molecules in B lymphomas is associated with an aggressive clinical course. Br J Haematol 100:655–663

3. Bernd HW, Ziepert M, Thorns C et al (2009) Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma—analyses of cases from two prospective randomized clinical trials. Haematologica 94:1569–1580

4. Bielska M, Bojo M, Klimkiewicz-Wojciechowska G et al (2015) Human leukocyte antigen-G polymorphisms influence the clinical outcome in diffuse large B-cell lymphoma. Genes Chromosomes Cancer 54:185–193

5. Booman M, Douwes J, Glas AM et al (2006) Mechanisms and effects of loss of human leukocyte antigen class II expression in immune-privileged site-associated B-cell lymphoma. Clin Cancer Res 12:2698–26705

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential Role of HLA-G on Solid Cancers;Interdisciplinary Cancer Research;2024

2. HLA-G: A Novel Immune Checkpoint for Solid Cancer Immunotherapy;Handbook of Cancer and Immunology;2023

3. Expression of the Non-classical HLA-E, -F, -G Molecules in the Tumour Microenvironment;Forum of Clinical Oncology;2022-12-01

4. Differentially Expressed Bone Marrow microRNAs Are Associated With Soluble HLA-G Bone Marrow Levels in Childhood Leukemia;Frontiers in Genetics;2022-06-14

5. HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges;Frontiers in Immunology;2021-06-30